Teladoc Health Inc/ US87918A1051 /
| 2024-04-18 9:59:58 PM | Chg. +0.05 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 13.19USD | +0.38% | 137,343 Turnover: 1.81 mill. |
-Bid Size: - | -Ask Size: - | 2.07 bill.USD | 0.00% | - |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
||||
|---|---|---|---|---|---|---|---|
| Property and Equipment | 10.3000 | 28.6000 | 27.2000 | ||||
| Intangible Assets | 225.5000 | 2,020.9000 | 1,910.3000 | ||||
| Long-Term Investments | - | - | - | ||||
| Fixed Assets | - | - | - | ||||
| Inventories | 0.0000 | 56.5000 | 73.1000 | ||||
| Accounts Receivable | 56.9000 | 169.3000 | 169 | ||||
| Cash and Cash Equivalents | 514.4000 | 733.3000 | 893.5000 | ||||
| Current Assets | 588 | 1,059.6000 | 1,225.4000 | ||||
| Total Assets | 1,602.8000 | 17,755.3000 | 17,734.6000 | ||||
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
||||
|---|---|---|---|---|---|---|---|
| Accounts Payable | 9.1000 | 46 | 47.3000 | ||||
| Long-term debt | - | 9.9000 | 9.3000 | ||||
| Liabilities to Banks | 0.0000 | 23.4000 | 22.6000 | ||||
| Provisions | 21.7000 | 102.1000 | 75.8000 | ||||
| Liabilities | 588.8000 | 1,871.5000 | 1,688.8000 | ||||
| Share Capital | .0730 | .1500 | .1600 | ||||
| Total Equity | 1,014 | 15,883.8000 | 16,045.8000 | ||||
| Minority Interests | - | - | - | ||||
| Total liabilities equity | 1,602.8000 | 17,755.3000 | 17,734.6000 | ||||
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
||||
|---|---|---|---|---|---|---|---|
| Revenues | 553.3000 | 1,094 | 2,032.7000 | ||||
| Depreciation (total) | 39 | 69.5000 | 204.2000 | ||||
| Operating Result | -80.4000 | -506.4000 | -265.6000 | ||||
| Interest Income | -29 | -60.5000 | -80.4000 | ||||
| Income Before Taxes | -109.5000 | -576 | -384.7000 | ||||
| Income Taxes | -10.6000 | -90.9000 | 44.1000 | ||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | ||||
| Net Income | -98.9000 | -485.1000 | -428.8000 | ||||
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
||||
|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 29.9000 | -53.5000 | 194 | ||||
| Cash Flow from Investing Activities | 25 | -591 | -73 | ||||
| Cash Flow from Financing | 35.1000 | 859.1000 | 40.9000 | ||||
| Decrease / Increase in Cash | 90 | 214.7000 | 162 | ||||
| Employees | 2,400 | 4,400 | 5,100 | ||||
